Cellino recently announced that its CEO, Dr. Nabiha Saklayen, has been awarded the first Tory Burch Fellowship at the International Genomics Institute (IGI). Cellino is a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies.
A leader in genome engineering
Nobel laureate Jennifer Doudna founded the IGI, a research institute at UC Berkeley, in 2014. The institute envisions a world in which genome-engineering innovations benefit humanity and are accessible to all. In addition to their scientific efforts, the IGI aims to advance public understanding of genome engineering. It also provides resources for the broader community and guides the ethical use of these technologies.
The Tory Burch Fellowship at the IGI supports a woman entrepreneur in leading, growing and scaling a business in genomics.
Moving towards a better future
“Women are underrepresented in scientific research and also less likely than men to commercialize their discoveries. They face the same barriers that women entrepreneurs typically face, including limiting stereotypes and a lack of access to capital, education and networks. This Fellowship program is the Tory Burch Foundation’s first contribution to the vital issue of women in STEM and we could not be more thrilled to be partnering with brilliant, trailblazing Jennifer Doudna and the Innovative Genomics Institute,” said Tory Burch, CEO at Tory Burch.
“Part of our mission at the Innovative Genomics Institute is to be the bridge from research to real-world impact,” said Dr. Doudna. “Dr. Saklayen’s work developing next-generation personalized therapies and her focus on making these innovations accessible and affordable embodies that vision and approach. We are delighted to partner with the Tory Burch Foundation and welcome Dr. Saklayen as our first fellow.”
“I am honored to receive the first Tory Burch Fellowship at the IGI and have Nobel Prize Laureate Dr. Jennifer Doudna and leading designer and entrepreneur Tory Burch as mentors,” said Nabiha Saklayen, Ph.D., CEO and Co-Founder at Cellino. “Dr. Doudna and I share a commitment to increasing accessibility of advanced therapies for patients the world over and I’m thrilled to collaborate closely with researchers at the IGI to further this mission.”
About the Tory Burch Fellowship
The one-year Fellowship with the Tory Burch Foundation includes:
- virtual education programming
- business guidance
- a grant for business education
- access to a private online peer community
IGI and UC Berkeley resources include:
- a network of cutting-edge researchers
- personalized coaching
- mentoring sessions
- an education grant, matching the funds from the Tory Burch Foundation
- up to $50,000 in research supplies
Nabiha Saklayen, Ph.D., co-founder and CEO at Cellino, is a Harvard-trained physicist. She aims to bring laser-enabled precision to increase accuracy in complex biological processes. Dr. Saklaten was a Pioneer in MIT Tech Review’s 35 Innovators under 35 list for her inventions in cellular laser editing. She is also on the 2019 Forbes 30 under 30 List for Healthcare. She received her Ph.D. in Physics from Harvard University as a Howard Hughes Medical Institute (HHMI) International Fellow.
About the Tory Burch Foundation
The Tory Burch Foundation empowers women and entrepreneurs in the United States by providing access to capital, education and digital resources. The Fellows Program has provided over $1.3M in grants to help women grow their businesses. The Tory Burch Capital Program, powered by Bank of America, has distributed more than $63 million in loans to more than 3,500 women entrepreneurs. The Foundation’s website, www.ToryBurchFoundation.org, is a go-to destination for women entrepreneurs. Each month, the Foundation provides online tools and digital education to more than 450,000 women. More than 10,000 women have created their business plans on ToryBurchFoundation.org.
About the Innovative Genomics Institute
The Innovative Genomics Institute (IGI) is a non-profit research institute. Jennifer Doudna founded the institute as a partnership between UC Berkeley and UC San Francisco. The IGI’s mission is to bridge revolutionary genome-editing tool development to affordable and accessible solutions in human health, climate and agriculture. We are working toward a world where genomic technology can treat genetic disease, enable sustainable agriculture and help achieve a carbon-neutral economy.
Cellino is an autologous regenerative medicine company developing an AI-guided single-cell laser editing platform for cell-based therapies. The company has developed a scalable platform that automates and standardizes autologous stem cell therapy production, accelerating the development of life-saving medicines for patients. Cellino is based in Cambridge, MA. For additional information, please visit www.cellinobio.com.